Newsletter Subject

Rare Syndrome After COVID Vaccines Described

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Sat, Dec 2, 2023 12:16 PM

Email Preheader Text

Weekly Review Saturday, December 02, 2023 THE BREAK ROOM CME SPOTLIGHT THE BREAK ROOM ADVERTISEMENT

[MEDPAGE TODAY]( Weekly Review Saturday, December 02, 2023 [Rare Syndrome After COVID Vaccines Described]( [Disgraced Surgeon Paolo Macchiarini Sees New Wave of Media Attention]( [Stephen Colbert Has Surgery for Ruptured Appendix]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Advancing cTTP Care Through Integration of the Latest Clinical Evidence]( [Tomato-Blood Pressure Link; Afib and Neuroticism; Nerve Stimulation for POTS]( [Patient Who Fell Off Operating Table Sues; Doc's Murder Trial; Hopkins Wants Retrial]( THE BREAK ROOM [Play Today's Wordosis: Our Medical Word Game]( ADVERTISEMENT [FDA Investigating 'Serious Risk' of Malignancy After CAR-T Therapy]( CME SPOTLIGHT [Hitting the Mark? Targeted Antibody-Based Therapy for Diffuse Large B-Cell Lymphoma]( [Medical Staff Credentialing Case Heads to New Jersey Supreme Court]( [Hospitals Say Some Medicare Advantage Plans Are Skirting CMS Rules]( [How Young Is Too Young for Botox?]( CME SPOTLIGHT [Amplifying New and Emerging Clinical Evidence in the Treatment and Management of Myelodysplastic Syndrome]( [Is the New Mpox 'Outbreak' Deadlier?]( [FDA Warns of Rare Life-Threatening Reaction to Anti-Seizure Drugs]( [U.S. Suicides Hit Record High; FDA Reviews Schizophrenia Drug; Psychology of Misinfo]( CME SPOTLIGHT [Individualizing Advanced/Metastatic HER2+ Breast Cancer Care: Evidence-Based and Patient-Centered Approaches]( [CDC Advisors' Infection Control Guidance Leaves Us Unprotected]( [COVID Tied to Changes in Brain Microstructure]( [Mounjaro vs Ozempic for Obesity; New Microwave Ablation System; GAHT Erythrocytosis]( CME SPOTLIGHT [Bladder Cancer: Assessing and Incorporating Novel Treatment Strategies]( [Stronger Quads May Lower Risk for Knee Replacement Surgery]( [Afib Guidelines Add New Stages, Upgrade Catheter Ablation]( [Early Interventions for Autism; Imaging After Stenting]( CME SPOTLIGHT [Unlocking the Power of PARP Inhibition in Metastatic Castration-Resistant Prostate Cancer]( [Can Paxlovid Improve Long COVID Symptoms?]( [Alzheimer's Tied to Military Service; Long COVID Sleepiness; NurOwn Tries Again]( [Cognitive Scores Improve With Personal Coaching]( CME SPOTLIGHT [Advancing AML Care: A Targeted Approach]( [Will Tomorrow's Medical Students Ever Practice Medicine?]( [We Need ICD Codes for Climate-Linked Health Outcomes]( [Days Before Surgery, Clerical Error Cuts Off Patient's Insurance]( CME SPOTLIGHT [Integrating Biomarkers and Guideline-Aligned Treatment Approaches Into Patient-Centered Care for Advanced/Metastatic Endometrial Cancer]( [No Laughing Matter: Women's Health Is Not a 'Women's Issue']( [Evolving Overdose Crisis Shakes Previously Effective Treatments]( [VTE Risk After Joint Replacement: Does Anticoagulant Choice Matter?]( [Swapping the White Coat for a Space Suit]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_DHE_Weekly?xid=nl_mpt_DHE_2023-12-02&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.